EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSHBUG00000008685
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSHBUG00000007432
Gene Symbol: LOC102312682
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSHBUG00000001128
Gene Symbol: LOC102306618
3 Cross references
156 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSHBUG00000007443
Gene Symbol: LOC102312378
3 Cross references
158 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor

Ensembl ID : ENSHBUG00000023442
Gene Symbol: LOC102306780
4 Cross references
200 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSHBUG00000008268
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSHBUG00000022300
Gene Symbol: LOC102295941
3 Cross references
209 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSHBUG00000012789
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSHBUG00000004388
Gene Symbol: LOC102292765
2 Cross references
204 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSHBUG00000010173
Gene Symbol: MIF
1 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSHBUG00000014460
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSHBUG00000002029
Gene Symbol: LOC102289696
2 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).